Filament Health and Reset Pharmaceuticals Strike Licensing Deal for Psilocybin Drug PEX010 | Benjamin Lightburn, CEO , Filament Health Corp. 00:10:00
Benjamin Lightburn is the CEO and Co-Founder of Filament Health Corp, a company focused on the development of natural psychedelic medicines. He is a seasoned entrepreneur with a strong background in botanical extraction and commercialization. Before founding Filament Health, he served as the CEO of Mazza Innovation, where he successfully scaled the company and spearheaded the development of proprietary botanical extraction technologies. Mazza Innovation was eventually acquired by Sensient Technologies for $26 million in 2018.
